Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

11 Nov 2008 16:47

RNS Number : 9529H
Verona Pharma PLC
11 November 2008
 



Verona Pharma plc

(the "Company")

Notice of interest

The Company announces that it has today received notification that following a disposal of shares on 10 November, 2008, Integrated Core Strategies (Europe) S.a.r.l. is now directly interested in 10,337,500 voting rights of the Company, which represents 4.80% of the current total voting rights of the Company.

For further information please contact:

Professor Clive Page, Verona Pharma plc

Tel: 07971 504 931

David Youngman / Adrian Kirk, WH Ireland Limited

Tel: 0161 832 2174

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGUGMCGUPRGQG

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS